UBE3A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.109400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.388000E-01
Normal-vs-Stage2
6.863200E-01
Normal-vs-Stage3
5.955600E-02
Normal-vs-Stage4
5.240200E-01
Stage1-vs-Stage2
2.569200E-01
Stage1-vs-Stage3
1.174040E-02
Stage1-vs-Stage4
6.911600E-01
Stage2-vs-Stage3
1.133240E-01
Stage2-vs-Stage4
1.813620E-01
Stage3-vs-Stage4
3.110500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.010600E-01
Normal-vs-AfricanAmerican
7.952200E-01
Normal-vs-Asian
4.340600E-01
Caucasian-vs-AfricanAmerican
3.095200E-01
Caucasian-vs-Asian
2.894200E-01
AfricanAmerican-vs-Asian
2.082600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.200000E-01
Normal-vs-Female
8.382000E-01
Male-vs-Female
2.821000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.066800E-01
Normal-vs-Age(41-60Yrs)
8.784800E-01
Normal-vs-Age(61-80Yrs)
5.511400E-01
Normal-vs-Age(81-100Yrs)
4.247200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.544160E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.181700E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.185000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.657700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.132050E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.677400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.402400E-01
Normal-vs-Daily Drinker
3.623400E-01
Normal-vs-Weekly Drinker
4.206000E-01
Normal-vs-Occasional Drinker
9.581400E-01
Normal-vs-Social Drinker
8.837600E-01
Non Drinker-vs-Daily Drinker
9.784800E-01
Non Drinker-vs-Weekly Drinker
9.805200E-01
Non Drinker-vs-Occasional Drinker
6.216000E-02
Non Drinker-vs-Social Drinker
1.936210E-01
Daily Drinker-vs-Weekly Drinker
9.653000E-01
Daily Drinker-vs-Occasional Drinker
8.546300E-02
Daily Drinker-vs-Social Drinker
2.287000E-01
Weekly Drinker-vs-Occasional Drinker
1.519560E-01
Weekly Drinker-vs-Social Drinker
3.207000E-01
Occasional Drinker-vs-Social Drinker
7.235200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.753700E-02
Normal-vs-Grade 2
3.962700E-03
Normal-vs-Grade 3
3.464600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.309200E-01
Grade 1-vs-Grade 3
5.095400E-01
Grade 1-vs-Grade 4
3.753700E-02
Grade 2-vs-Grade 3
5.957200E-01
Grade 2-vs-Grade 4
3.962700E-03
Grade 3-vs-Grade 4
3.464600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.417000E-01
Normal-vs-NonDiabetic
6.260200E-01
Diabetic-vs-NonDiabetic
1.543570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.653400E-01
Normal-vs-NoPancreatitis
6.146600E-01
Pancreatitis-vs-NoPancreatitis
4.733000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.444400E-01
Normal-vs-N1
7.306000E-01
N0-vs-N1
9.784600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.396600E-01
Normal-vs-TP53-NonMutant
9.847600E-01
TP53-Mutant-vs-TP53-NonMutant
8.744000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
